Financial statements Arapharma Polska
Balance sheet of Arapharma Polska
Company age:
Age:
8 y. 2 m. 30 d.
Share capital:
Share capital:
42 600 PLN
Balance sheet data of ARAPHARMA POLSKA
|
Year
|
2018
|
2019
|
|---|---|---|
| Total assets | 429 681,10 | 441 093,85 |
| A. Fixed assets | 0,00 | 0,00 |
| B. Current assets | 429 681,10 | 441 093,85 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 |
| Total liabilities | 429 681,10 | 441 093,85 |
| A. Equity | -897 530,80 | -1 816 199,36 |
| B. Liabilities and provisions for liabilities | 1 327 211,90 | 2 257 293,21 |
| I. Long-term liabilities | 948 705,26 | 1 787 416,50 |
| II. Short-term liabilities | 378 506,64 | 469 876,71 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.